About Frank Haluska
Frank Haluska is a president and chief executive officer, director at Kestrel Therapeutics.
Frank Haluska first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Frank Haluska in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Frank Haluska works with at each company, as listed on that company's latest Form D.
Kestrel Therapeutics Inc. · Form D, Aug 12, 2025
NS
Nicholas Saccomano
Director
DP
Denis Patrick
Director
BS
Barbara Sosnowski
Director
OK
Omar Khalil
Director
AP
Andrew Phillips
Director